Incruse Ellipta
Incruse Ellipta is a medicine authorised by Swissmedic under authorisation number 65091. The authorisation holder is GlaxoSmithKline AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 29 September 2014 and the authorisation is valid without a time limit. ATC code R03BB07 places the medicine in the group Drugs for obstructive airway diseases.
| Authorisation number | 65091 |
|---|---|
| Name | Incruse Ellipta |
| Full name | Incruse Ellipta, einzeldosiertes Pulver zur Inhalation |
| Authorisation holder | GlaxoSmithKline AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | B · Prescription only |
| ATC code | R03BB07 |
| First authorisation | 29 September 2014 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Incruse Ellipta, einzeldosiertes Pulver zur Inhalation | B | 29 September 2014 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 30 | Einzeldose(n) | R03BB07 | 03.04.3. | B |
| 2 | 3 x 30 | Einzeldose(n) | R03BB07 | 03.04.3. | B |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Incruse Ellipta authorised in Switzerland?
Yes. Incruse Ellipta is authorised by Swissmedic under authorisation number 65091, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Incruse Ellipta have?
Incruse Ellipta is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Incruse Ellipta?
The authorisation holder is GlaxoSmithKline AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.